Margaret Ragni

Dept of Medicine, University of Pittsburgh Medical Center and Hemophilia Center of Western Pennsylvania, United States of America

Margaret V. Ragni MD, MPH

Academic positions:
- Professor of Medicine, Division Hematology/Oncology
- Director, Hemophilia Center of Western PA

All industry positions (in last five years):

Research interests:
- Epidemiology of HIV/HCV infection in hemophilia
- Immunogenetics of hemophilia inhibitors
- Dendritic cell tolerance in hemophilia mouse
- Genetics and clinical phenotype of VWD
- New treatments for Von Willebrand Disease

Any other information:
Dr. Ragni is a member of the Medical and Scientific Advisory Board of the National Hemophilia Foundation, the GCRC advisory board, and serves on several editorial boards. She serves as ad hoc member on NHLBI Hemostasis & Thrombosis study sections and holds a number of other positions including:
- Member, American Society of Hematology Government Affairs Committee and Development Task Force;
- Fellow, American College of Physicians;
- Member, Hemophilia & Thrombosis Research Society of North America, Secretary and Executive Board (1994-97)
- Kenneth E. Schuit Award, Dean’s Master Educator, 1998, University of Pittsburgh School of Medicine;
- Kenneth M. Brinkhous Award for Excellence in Clinical Research, 1998, National Hemophilia Foundation.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Bleeding & Coagulation Disorders (since 15 November 2005)

Links

http://www.upci.upmc.edu/research/clinical/hemmalig/index.html

All recent recommendations

• 9.0
  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
  Recommended by Margaret Ragni
  
• 6.0
  Response to desmopressin is influenced by the genotype and phenotype in type 1 Von Willebrand Disease (VWD): results from the European study MCMDM-1VWD.
  Recommended by Margaret Ragni
  
• 6.0
  Management of venous thromboembolism: a systematic review for a practice guideline.
  Recommended by Margaret Ragni
  
• 3.0
  Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
  Recommended by Margaret Ragni
  
• 3.0
  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
  Recommended by Margaret Ragni